HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease.

AbstractOBJECTIVES:
To analyze the expression and potential role of interleukin (IL) 21 in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.
METHODS:
Blood samples were obtained from patients with VKH disease and from healthy control subjects. Serum IL-21 level and IL-21 messenger RNA (mRNA) expression by peripheral blood mononuclear cells (PBMCs) were determined by enzyme-linked immunosorbent assay and by reverse transcriptase-polymerase chain reaction, respectively. Interleukin 17 and interferon γ levels in the supernatants of PBMCs and CD4(+) T cells cultured with anti-CD3 and anti-CD28 antibodies in the presence or absence of recombinant IL-21 were detected by enzyme-linked immunosorbent assay.
RESULTS:
The results showed a significantly increased serum IL-21 level, as well as higher IL-21 mRNA expression by PBMCs, in patients having chronic or recurrent active VKH disease compared with patients having inactive VKH disease and with controls. In vitro experiments showed that recombinant IL-21 significantly increased IL-17 production by PBMCs and by CD4(+) T cells from patients and from controls. However, recombinant IL-21 did not affect interferon γ expression by PBMCs or by CD4(+) T cells.
CONCLUSION:
Interleukin 21 may be involved in the pathogenesis of chronic or recurrent VKH disease, possibly by promoting IL-17 secretion.
CLINICAL RELEVANCE:
Findings from the present study suggest that IL-21 may be a potential target in the development of therapy for VKH disease.
AuthorsFuzhen Li, Peizeng Yang, Xiaoli Liu, Chaokui Wang, Shengping Hou, Aize Kijlstra
JournalArchives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 128 Issue 11 Pg. 1449-54 (Nov 2010) ISSN: 1538-3601 [Electronic] United States
PMID21060047 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-17
  • Interleukins
  • RNA, Messenger
  • Recombinant Proteins
  • Interferon-gamma
  • interleukin-21
Topics
  • Adult
  • CD4-Positive T-Lymphocytes (drug effects, metabolism)
  • Cells, Cultured
  • Chronic Disease
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gene Expression Regulation (physiology)
  • Humans
  • Interferon-gamma (metabolism)
  • Interleukin-17 (biosynthesis)
  • Interleukins (blood, genetics, pharmacology)
  • Leukocytes, Mononuclear (drug effects, metabolism)
  • Male
  • RNA, Messenger (genetics)
  • Recombinant Proteins (pharmacology)
  • Recurrence
  • Reverse Transcriptase Polymerase Chain Reaction
  • Uveomeningoencephalitic Syndrome (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: